ストックスクリーナーアプリを入手
0.2036
6.39%
-0.0139
プレマーケット:
.20
-0.0036
-1.77%
前日終値:
$0.2175
開ける：
$0.2197
24時間の取引高:
1.47M
Relative Volume:
0.82
時価総額：
$8.82M
収益：
$6.14M
当期純損益:
$-24.81M
株価収益率:
-0.0818
EPS:
-2.49
ネットキャッシュフロー:
$-27.40M
1週間 パフォーマンス:
+19.06%
1か月 パフォーマンス:
-46.01%
6か月 パフォーマンス:
-59.46%
1年 パフォーマンス:
-91.59%
1日の値動き範囲:
$0.20
$0.2197
1週間の範囲:
$0.177
$0.2237
52週間の値動き範囲:
$0.1151
$2.37
Geovax Labs Inc Stock (GOVX) Company Profile
GOVX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
0.2036 | 9.42M | 6.14M | -24.81M | -27.40M | -2.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-15 | 繰り返されました | Alliance Global Partners | Buy |
| 2025-04-15 | 繰り返されました | D. Boral Capital | Buy |
| 2024-11-11 | 開始されました | Alliance Global Partners | Buy |
| 2024-07-16 | 開始されました | ROTH MKM | Buy |
| 2020-11-19 | 開始されました | Maxim Group | Buy |
Geovax Labs Inc (GOVX) 最新ニュース
Why GeoVax Labs Inc. stock is popular among millennials - ulpravda.ru
How GeoVax Labs Inc. stock reacts to bond yieldsStock Split Announcements & Free Risk Assessment and Control - bollywoodhelpline.com
GeoVax Labs to Outline Clinical Progress and Strategic Priorities at Major Healthcare Conferences - citybuzz -
GeoVax Labs, Inc. to Review Progress and Strategic Priorities During Biotech Showcase 2026 and J.P. Morgan Healthcare Conference Week - Yahoo Finance
Is GeoVax Labs Inc. Equity Warrant stock safe for conservative investors2026 world cup usa national team round of 16 young talents build up play odds analysis preview - ulpravda.ru
Why GeoVax Labs Inc. stock appeals to dividend seekers2026 world cup usa national team quarterfinals key players counter attacking expert forecast analysis - ulpravda.ru
GeoVax shareholders approve warrant exercises - MSN
GOVX News Today | Why did GeoVax Labs stock drop today? - MarketBeat
GeoVax Labs (NASDAQ:GOVX) Shares Up 21.1% – Should You Buy? - Defense World
Is GeoVax Labs Inc a good long term investmentSupport Level Holds & Big Returns Small Capital - earlytimes.in
Sentiment Watch: Why GeoVax Labs Inc stock is favored by top institutionsQuarterly Performance Summary & Real-Time Market Sentiment Reports - moha.gov.vn
GeoVax Labs Inc Equity Warrant Stock Analysis and ForecastDividend Yield Trends & Best Stocks For Explosive Growth - earlytimes.in
Analyst Calls: What dividend safety score for GeoVax Labs Inc Equity Warrant stockQuarterly Trade Report & AI Powered Market Entry Ideas - moha.gov.vn
GeoVax Labs announces public equity offering for liquidity - MSN
Is Now the Best Entry Point for Orient Cement Limited StockCovered Call Writing & Fast Profit Strategies - earlytimes.in
GeoVax Labs Announces Public Equity Offering for Liquidity - The Globe and Mail
GeoVax Labs Signs Multiple Material Agreements - TradingView — Track All Markets
Market Wrap: Can GeoVax Labs Inc stock deliver sustainable ROE2025 Price Momentum & Expert Approved Momentum Ideas - moha.gov.vn
Why GeoVax Labs Inc. stock is recommended by analystsQuarterly Earnings Report & Proven Capital Preservation Methods - Улправда
Is GeoVax Labs Inc. stock a bargain at current levelsJuly 2025 Closing Moves & Safe Investment Capital Preservation Plans - Улправда
Can GeoVax Labs Inc. stock sustain institutional interestGold Moves & Fast Moving Trade Plans - Улправда
Analyst Downgrade: How GeoVax Labs Inc. Equity Warrant stock reacts to inflationary pressuresJuly 2025 Decliners & Accurate Entry and Exit Point Alerts - Улправда
Why GeoVax Labs Inc. stock is a must watch in 20252025 Market Overview & Stock Portfolio Risk Management - Улправда
Would You Still Hold Geovax Labs Stock If It Fell Another 30%? - Trefis
Geovax Labs Stock Slides 61% With A 9-Day Losing Spree - Trefis
Will GeoVax Labs Inc. stock outperform Nasdaq indexPrice Action & Free Low Drawdown Momentum Trade Ideas - Улправда
GeoVax Announces $3.2 Million Public Offering to Fund Clinical-Stage Vaccine and Cancer Therapy Development - citybuzz -
Why GeoVax Labs Inc. stock attracts global investors2025 Market WrapUp & Weekly Return Optimization Alerts - Улправда
Dow Gains Over 200 Points; Conagra Shares Fall After Q2 Results - Sahm
What dividend safety score for GeoVax Labs Inc. Equity Warrant stock2025 Trade Ideas & Risk Managed Trade Strategies - DonanımHaber
GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering - Yahoo Finance
How GeoVax Labs Inc. Equity Warrant stock responds to policy changesJuly 2025 Closing Moves & Daily Oversold Stock Bounce Ideas - DonanımHaber
How GeoVax Labs Inc. stock performs after earnings2025 Support & Resistance & Verified Technical Trade Signals - DonanımHaber
Is GeoVax Labs Inc. Equity Warrant stock attractive for growth ETFs2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - DonanımHaber
Can GeoVax Labs Inc. Equity Warrant stock beat market expectations this quarterMarket Sentiment Summary & Weekly Return Optimization Plans - DonanımHaber
Why GeoVax Labs Inc. stock remains a top recommendationDip Buying & AI Powered Buy and Sell Recommendations - DonanımHaber
Why GeoVax Labs Inc. Equity Warrant stock could be next big winner2025 Big Picture & Daily Entry Point Trade Alerts - Улправда
How currency fluctuations impact GeoVax Labs Inc. stockCPI Data & Weekly Setup with ROI Potential - Улправда
Market Rankings: Can GeoVax Labs Inc. stock sustain institutional interestJuly 2025 Pullbacks & Real-Time Volume Spike Alerts - Улправда
Market Review: Why GeoVax Labs Inc. stock is a must watch in 20252025 Performance Recap & Capital Efficiency Focused Ideas - Улправда
GeoVax Receives EMA Scientific Advice for Phase 3 Trial of Mpox and Smallpox Vaccine Candidate - citybuzz -
GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine - Yahoo Finance
GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA - Yahoo Finance
Sentiment Watch: Why GeoVax Labs Inc. stock appeals to dividend seekersJuly 2025 Decliners & AI Forecast Swing Trade Picks - ulpravda.ru
GeoVax Advances Domestic Mpox Vaccine Production with Manufacturing Milestone - citybuzz -
GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026 - Yahoo Finance
Geovax Labs Inc (GOVX) stock: A year of ups and downs - uspostnews.com
GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design - Yahoo Finance
GeoVax’s Next-Generation COVID-19 Vaccine Shows Superior T-Cell Response in CLL Patients, Trial Advances Exclusively – citybuzz - citybuzz
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients - Yahoo Finance
What drives GeoVax Labs Inc stock priceMarket Breadth Indicators & Buy Sell Timing Alerts - earlytimes.in
Geovax Labs Inc (GOVX) 財務データ
収益
当期純利益
現金流量
EPS
28.63%
大文字化:
|
ボリューム (24 時間):